Effects of a peripherally acting µ-opioid receptor antagonist for the prevention of recurrent acute pancreatitis: study protocol for an investigator-initiated, randomized, placebo-controlled, double-blind clinical trial (PAMORA-RAP trial)

This study investigates if naldemedine can change the natural course of pancreatitis in patients with recurrent acute pancreatitis and improve patient outcomes.Trial registrationEudraCT no. 2021 –000069-34. ClinicalTrials.gov NCT04966559. Registered on July 8, 2021.
Source: Trials - Category: Research Source Type: clinical trials